Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.
about
Pre-medication practices and incidence of infusion-related reactions in patients receiving AMPHOTEC: data from the Patient Registry of Amphotericin B Cholesteryl Sulfate Complex for Injection Clinical Tolerability (PRoACT) registry.Canadian clinical practice guidelines for invasive candidiasis in adults.Updated guidelines for managing fungal diseases in hematology patients.Candida tropicalis in human disease.Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014.Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand.Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology.Optimising antifungal therapy for individual patients.Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.Antifungal guidelines.
P2860
Q33371455-2FE7D44E-2C14-4E58-B836-10B53C47C54BQ34237335-B3BE86ED-6D3E-4575-8629-EACA048E4442Q37785548-C407E5C9-CFFA-4696-A10D-46D6A7279842Q37794979-8E4975EF-7432-4EFB-AEBF-FB410BF5CFBBQ37833638-1D74F6E4-1309-47E6-8DDC-CDFA99112BADQ38284447-84209792-FEE7-4ACE-9486-9C84E253230DQ38284453-6E0B005A-1F13-4788-97B4-09446AA2A026Q40317253-C6BA46B3-F82B-4CBD-A4C1-F759CFBA68DCQ43146558-FE750171-3FF9-49EA-B76B-ADDB37038321Q44846156-DC6D16EE-6035-4F0D-98B5-11B4D2F477DBQ46758158-0926CAF1-9CB1-4878-92B3-7CE95DAC439DQ47608903-E0F741E2-82F8-4A5F-8404-B2D8B6E49D63
P2860
Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Guidelines for the use of anti ...... Candida and mould infections.
@ast
Guidelines for the use of anti ...... Candida and mould infections.
@en
type
label
Guidelines for the use of anti ...... Candida and mould infections.
@ast
Guidelines for the use of anti ...... Candida and mould infections.
@en
prefLabel
Guidelines for the use of anti ...... Candida and mould infections.
@ast
Guidelines for the use of anti ...... Candida and mould infections.
@en
P2093
P2860
P50
P1476
Guidelines for the use of anti ...... e Candida and mould infections
@en
P2093
P2860
P304
P356
10.1111/J.1444-0903.2004.00541.X
P577
2004-04-01T00:00:00Z